IT202200007238A1 - Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche - Google Patents

Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche Download PDF

Info

Publication number
IT202200007238A1
IT202200007238A1 IT102022000007238A IT202200007238A IT202200007238A1 IT 202200007238 A1 IT202200007238 A1 IT 202200007238A1 IT 102022000007238 A IT102022000007238 A IT 102022000007238A IT 202200007238 A IT202200007238 A IT 202200007238A IT 202200007238 A1 IT202200007238 A1 IT 202200007238A1
Authority
IT
Italy
Prior art keywords
acetylcysteine
vitamin
composition including
nutraceutical compositions
related pharmaceutical
Prior art date
Application number
IT102022000007238A
Other languages
English (en)
Inventor
Lorenzo Secondini
Mietta Catera
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Priority to IT102022000007238A priority Critical patent/IT202200007238A1/it
Priority to PCT/IB2023/053745 priority patent/WO2023199244A1/en
Publication of IT202200007238A1 publication Critical patent/IT202200007238A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
IT102022000007238A 2022-04-12 2022-04-12 Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche IT202200007238A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000007238A IT202200007238A1 (it) 2022-04-12 2022-04-12 Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
PCT/IB2023/053745 WO2023199244A1 (en) 2022-04-12 2023-04-12 Composition comprising n-acetylcysteine, vitamin d and preferably glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000007238A IT202200007238A1 (it) 2022-04-12 2022-04-12 Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Publications (1)

Publication Number Publication Date
IT202200007238A1 true IT202200007238A1 (it) 2023-10-12

Family

ID=82694019

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000007238A IT202200007238A1 (it) 2022-04-12 2022-04-12 Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Country Status (1)

Country Link
IT (1) IT202200007238A1 (it)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06279397A (ja) * 1993-03-31 1994-10-04 Eisai Co Ltd アミノ酸系末梢神経障害改善剤
WO1998029101A1 (en) * 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
WO2005067972A1 (en) * 2003-12-31 2005-07-28 Integrative Health Consulting, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
US20070116779A1 (en) * 2005-11-23 2007-05-24 Elizabeth Mazzio Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease
WO2010082837A1 (en) * 2009-01-16 2010-07-22 Jan Anne Lyftogt Medicament for the treatment of pain and inflammation
US10105419B2 (en) * 2015-02-13 2018-10-23 Eastern Vision Limited Dietary supplements and formulations
WO2022043407A1 (fr) * 2020-08-25 2022-03-03 Laouarem Yousra Compositions destinées au traitement des troubles neurologiques

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06279397A (ja) * 1993-03-31 1994-10-04 Eisai Co Ltd アミノ酸系末梢神経障害改善剤
WO1998029101A1 (en) * 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
WO2005067972A1 (en) * 2003-12-31 2005-07-28 Integrative Health Consulting, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
US20070116779A1 (en) * 2005-11-23 2007-05-24 Elizabeth Mazzio Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease
WO2010082837A1 (en) * 2009-01-16 2010-07-22 Jan Anne Lyftogt Medicament for the treatment of pain and inflammation
US10105419B2 (en) * 2015-02-13 2018-10-23 Eastern Vision Limited Dietary supplements and formulations
WO2022043407A1 (fr) * 2020-08-25 2022-03-03 Laouarem Yousra Compositions destinées au traitement des troubles neurologiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ABDUL BASIT ET AL: "Vitamin D for the treatment of painful diabetic neuropathy", BMJ OPEN DIABETES RESEARCH & CARE, vol. 4, no. 1, 1 February 2016 (2016-02-01), pages e000148, XP055645761, DOI: 10.1136/bmjdrc-2015-000148 *
LEMON J A ET AL: "A dietary supplement abolishe age-related cognitive defcline in transgenic mice expressing elevated free radical processes", EXPERIMENTAL BIOLOGY AND MEDICINE, SAGE PUBLICATIONS LTD, GB, vol. 228, 1 January 2003 (2003-01-01), pages 800 - 810, XP002436865, ISSN: 1535-3702 *
SAGARA M ET AL: "INHIBITION OF DEVELOPMENT OF PERIPHERAL NEUROPATHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS WITH N-ACETYLCYSTEINE", DIABETOLOGIA, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 39, no. 3, 1 January 1996 (1996-01-01), pages 263 - 269, XP000870081, ISSN: 0012-186X, DOI: 10.1007/BF00418340 *
UENO YUKI ET AL: "Biochemical and Molecular Actions of Nutrients Research Communication Dietary Glutathione Protects Rats from Diabetic Nephropathy and Neuropathy", 1 May 2002 (2002-05-01), XP093000918, Retrieved from the Internet <URL:https://academic.oup.com/jn/article/132/5/897/4687266?login=true> [retrieved on 20221122] *

Similar Documents

Publication Publication Date Title
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
ES2556585T3 (es) Composiciones que comprenden sulfato de salbutamol
BRPI0608402B8 (pt) compostos de flavonóide e composições compreendendo os mesmos
AR065246A1 (es) Composiciones para mejorar la absorcion gastrointestinal de nutrientes y de farmacos
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
AR051397A1 (es) Composicion farmaceutica
BRPI0617294B8 (pt) composição farmacêutica em gel hidroalcóolico e uso de testosterona
NO20082376L (no) Farmasoytiske sammensetninger
WO2007036802A3 (en) Sublingual dosage form comrising vitamin d analogue, in particular calcitriol
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
NO20054945L (no) Orale formulering av cladribin
BR112016010875A8 (pt) Composição útil para a promoção da fertilidade feminina
ECSP10010167A (es) Composiciones oftálmicas novedosas
DK3519416T3 (da) Chroman, isochroman og dihydroisobenzofuranderivater som mglur2-negative allosteriske modulatorer, sammensætninger og anvendelse deraf
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
EP3915972A4 (en) CAPSID PROTEIN ASSEMBLY INHIBITOR WITH A FIVE-MEMBER N-HETEROCYCLIC RING, PHARMACEUTICAL COMPOSITION AND USES THEREOF
DE602006002303D1 (de) Lebensmittelzusammensetzung zur Vorbeugung des Fragilitätssyndrom bei Senioren
IT202200007229A1 (it) Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
IT202200007238A1 (it) Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
IL304247A (en) History of spirocyclohexane, pharmaceutical preparations containing them and their use as anti-apoptotic inhibitors
IT202200007226A1 (it) Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
IT202200007232A1 (it) Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
TR201909773T4 (tr) Nöropatilerin ve veya nöropatik ağrının tedavisine yönelik bir bileşim.